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Introduction: Metabolomics, rapidly evolving field of measuring all endogenous metabolites 
in a cell or body fluid, provides a functional readout of the physiological state of the human body. 
Most importantly, genetic variants associated with a specific metabolite level, and with a defined 
disorder, might provide access to the underlying molecular disease-causing mechanisms. The 
main goal of this research is identifying metabolically interpretable genetic facrors predispoding 
to manifestation and progression of various diseases. 
Methods: We conducted metabolic studies by the case-control design. There was conducted an 
isolation of polar and non-polar metabolites from blood plasma, which were further separated into 
the HILIC bond column by HPLC-MS with the TOF (time-of-flight) detector. The processing of the 
obtained data was carried out on the public software PCDL Metlin Metabolite Database, XCMSonline. 
Statistical processing of data was carried out on MetaboAnalyst 3.0. 
Results: There was revealed a difference in the spectra and in the amount of metabolites in 
various pathologies. We have investigated the following diseases: thyroid cancer, childhood food 
allergy and rheumatoid arthritis. There was revealed difference in the metabolic spectrum in 
children diagnosed with congenital food allergies in comparison with their parents. Specific 
biomarkers, such as L-methionine, 3-hydroxy-trimethyl lysine, etc., have been detected in patients 
diagnosed with thyroid cancer. Fingerprinting analysis of metabolites by free access software 
revealed differences between the case and control cohorts and also demonstrated notable 
discrimination between the RA and RA-OP cohorts. 
Conclusions: As a result of our research we want to determine specific metabolically 
interpretable and reliable genetic factors along with metabolic pathways, which might be shared or 
differed between case and control groups and might provide insight into the extent to which the 
process of pathological changes occurs and progresses. All over the world, research on the problems 
of aging is carried out for this purpose and preventive diagnostics, and the prevention of the 
development of diseases will help healthy longevity. 
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